PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pavlov University, Saint-Petersburg, Russian Federation. oksana.stanevich@gmail.com.\', \'State City Hospital №52, Moscow, Russian Federation.\', \'First Sechenov Moscow State Medical University of the Ministry of Healthcare of the Russian Federation, Moscow, Russia.\', \'North-Western State Medical University Named After I.I. Mechnikov, Saint-Petersburg, Russian Federation.\', \'State City Hospital №20, Saint-Petersburg, Russian Federation.\', \'Pavlov University, Saint-Petersburg, Russian Federation.\', \'Pirogov Russian National Research Medical University (RNRMU) of the Ministry of Healthcare of the Russian Federation, Moscow, Russia.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s12879-021-06982-z
?:hasPublicationType
?:journal
  • BMC infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 34937556
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.576
?:rankingScore_hIndex
  • 80
is ?:relation_isRelatedTo_publication of
?:title
  • Ruxolitinib versus dexamethasone in hospitalized adults with COVID-19: multicenter matched cohort study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all